Steroid Analysis Without Derivatization
Steroid testing is commonly associated with sports doping testing to monitor athletes for performance-enhancing compounds, but it also important in the food industry for consumer safety. A new method using high-temperature liquid chromatography with photodiode detection and isotope ratio mass spectrometry (HT?LC?PDA?IRMS) that does not require sample derivatization and uses water as the eluent has been developed by scientists at the University of Duisberg-Essen in Essen, Germany.1
Steroid testing is commonly associated with sports doping testing to monitor athletes for performance-enhancing compounds, but it also important in the food industry for consumer safety. A new method using high-temperature liquid chromatography with photodiode detection and isotope ratio mass spectrometry (HT–LC–PDA–IRMS) that does not require sample derivatization and uses water as the eluent has been developed by scientists at the University of Duisberg-Essen in Essen, Germany.1
An LC–IRMS coupling on the basis of a chemical combustion interface was commercialized in 2004. Corresponding author Maik A. Jochmann told The Column: “In this interface, carbon-containing substances in the LC effluent are chemically oxidized to carbon dioxide. The developed carbon dioxide is then separated by a membrane separation unit into a dry helium gas stream, further dried, and transferred into the IRMS. The main problem is that the LC separation has to be accomplished with water as eluent. Thus, the method is restricted to ion chromatography or separations with mixed-mode phases.”
Together with the Institute of Energy and Environmental Technology (an institute associated with the University of Duisberg‑Essen), Jochmann and his colleagues developed the method based on high-temperature HPLC to differentiate between synthetic and natural caffeine. Jochmann said: “With this work, the scope of LC–IRMS applications has been extended to relatively nonpolar compounds that still require a derivatization if measured by GC–IRMS.”
A mixture of 19-norandrosterone, testosterone, epitestosterone, androsterone, and 5β-pregnane-3α,17α,20α-triol was separated using a C4 column, and water as eluent. The method was then applied to the analysis of a pharmaceutical gel containing testosterone. Jochmann said: “The most important result is that with this method no derivatization of testosterone found in pharmaceutical preparations is necessary for carbon stable isotope analysis. For other matrices, such as urine, the main challenge will be the sample cleanup before the chromatographic separation.”
When asked by The Column about future work, Jochmann said: “Currently, we mainly work on the compound-specific analysis of pesticides by LC–IRMS. Here we think that the method has a high potential to quantify and elucidate biodegradation processes of such compounds in the environment.” — B.D.
Reference
1. L. Zhang et al., Analytical Chemistry 86, 2297–2302 (2014).
This article is from The Column. The full issue can be found here:
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
Inside the Laboratory: The Richardson Group at the University of South Carolina
November 20th 2024In this edition of “Inside the Laboratory,” Susan Richardson of the University of South Carolina discusses her laboratory’s work with using electron ionization and chemical ionization with gas chromatography–mass spectrometry (GC–MS) to detect DBPs in complex environmental matrices, and how her work advances environmental analysis.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Infographic: Be confidently audit ready, at any time and reduce failures in pharma QC testing
November 20th 2024Discover how you can simplify the audit preparation process with data integrity dashboards that provide transparency to key actions, and seamlessly track long-term trends and patterns, helping to prevent system suitability failures before they occur with waters_connect Data Intelligence software.
Critical Role of Oligonucleotides in Drug Development Highlighted at EAS Session
November 19th 2024A Monday session at the Eastern Analytical Symposium, sponsored by the Chinese American Chromatography Association, explored key challenges and solutions for achieving more sensitive oligonucleotide analysis.
